The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Danielle Rasooly, PhD, of the Division of Aging at Brigham and Women’s Hospital, is the co-corresponding author of a paper published in Nature Cardiovascular Research, “Large-scale multi-omics ...

Coherus BioSciences, Inc.’s CHRS share price has dipped by 12.59%, which has investors questioning if this is right time to ...

Novartis' two-drug regimen of Tafinlar and Mekinist has been approved by the FDA as the first therapy for solid tumours that have a BRAF V600E mutation – regardless of where they occur in the body.

The Philippine Press Institute (PPI) and Novartis Healthcare Philippines ... we consistently rank among the world’s top companies investing in research and development. Novartis products reach more ...

In a statement, Novartis said that if generics launch in the US early, its fiscal year 2022 sales could be reduced by $3 billion, although it is still forecasting "mid-single digit range growth ...

Founded in 1991, the Institute for Justice is what a civil liberties law firm should be. As the national law firm for liberty, we stick to a clear mission engaging in cutting-edge litigation and ...

This organization has no public members. You must be a member to see who’s a part of this organization.

Capmatinib hydrochloride is under clinical development by Novartis and currently in Phase II for Metastatic ... provided the underlying data, research, and analysis used to produce this article.

The Summer Undergraduate Program in Biomedical Ethics Research provides students with a mentored research experience that assists them in preparing for careers in healthcare, science, law or bioethics ...

Our research is aimed at understanding the molecular and cellular processes underlying human health and disease with a key aim to translate this research into diagnostic and therapeutic applications.